CEJ Capital is a venture capital arm of CYBERDYNE.
CEJ Capital is a venture capital arm of CYBERDYNE. It engages in the creation of cybernics industry, management, and management of growth promotion investment business association property.
Announced Date | Fund Name | Money Raised | |
---|---|---|---|
Jul 12, 2018 | Cybernics Excellence Japan Fund I | ¥9.20B |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 21, 2021
GAIA BioMedicine
|
Series B | ¥1.30B | Compliance | — |
Mar 23, 2021
Jiksak Bioengineering
|
Series B | — | Biometrics | Yes |
Sep 7, 2020
ANSeen
|
Series B | ¥0.90B | Industrial Manufacturing | — |
Apr 20, 2020
AMI Japan
|
Series Unknown | ¥490M | Health Care | — |
Feb 28, 2020
Kringle Pharma
|
Series Unknown | ¥0.95B | Biotechnology | — |
CEJ Capital has had 1 exits. CEJ Capital most notable exits include Kringle Pharma
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 28, 2020 | Kringle Pharma | IPO | Biotechnology | Detail |